Skip to content
Search

Latest Stories

Community pharmacies in Wales get 6% funding increase

Community pharmacies in England are still awaiting progress on CPCF negotiations for 2024/25
Jeremy Miles, cabinet secretary for health and social care (Photo credit: www.gov.wales )

The £9.9 million increase is intended to address “immediate pressures” facing community pharmacies while also supporting longer-term reform plans  

The Welsh government has reached an agreement with the NHS and Community Pharmacy Wales (CPW)—the statutory representative body for all community pharmacies—on a six per cent funding increase as part of the 2024/25 Community Pharmacy Contractual Framework (CPCF).

The £9.9 million increase will bring the total CPCF funding to £175 million per year, representing a 24 per cent rise in funding since 2017.


In a statement published on 20 December 2024, Jeremy Miles, cabinet secretary for health and social care, said that the additional investment will be used to address “both immediate pressures facing community pharmacies and to maintain momentum on our longer-term ambitions for reform.”

Miles also said that the government would continue to invest in integrating pharmacies in primary care clusters, developing the skills and scope of practice of the wider community pharmacy workforce including pharmacy technicians, and the Choose Pharmacy IT system.

In contrast, community pharmacies in England are still awaiting progress on CPCF negotiations for 2024/25.

Last month, Community Pharmacy England (CPE) warned of the sector's worsening financial situation, urging ministers to provide immediate funding relief.

In a letter to ministers, CPE chief executive Janet Morrison warned that the CPCF negotiations delay could lead to widespread pharmacy closures.

“We are now eight months into the 2024/25 financial year with no financial settlement in sight: this is disastrous from a business planning perspective, falls short of proper economic regulation, and the continuation of current underfunding is proving catastrophic for community pharmacies.”

Highlighting that more community pharmacies are falling into “debt and administration,” she cautioned that without urgent remedial action, there will not be a “community pharmacy sector left to deliver the Contractual Framework, let alone the future ambitions of the government and the NHS.”

Health secretary Wes Streeting and pharmacy minister Stephen Kinnock have confirmed that CPCF negotiations for England will commence in early 2025.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less